Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2300060	Risankizumab注射液（ABBV-066)	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-05-16					view
JXSL2000218	Risankizumab注射液（ABBV-066)	risankizumab	Injection	Biological Products(2.2)	Import Drug Application	2020-12-10	AbbVie Inc.	Abbvie Inc	In Review	2020-12-09	view
JXSB2000054	Risankizumab注射液（ABBV-066)	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2020-12-25	AbbVie Inc.	Abbvie Inc	In Review	2021-05-09	view
JXSB2300059	Risankizumab注射液（ABBV-066)	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-05-16					view
JXSB2000055	Risankizumab注射液（ABBV-066)	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2020-12-25	AbbVie Inc.	Abbvie Inc	In Review	2021-05-09	view
JXSB2300061	Risankizumab注射液（ABBV-066)	risankizumab	Injection	Biological Products(2.2)	Supplementary Application	2023-05-16					view
JXSL2000219	Risankizumab注射液（ABBV-066)	risankizumab	Injection	Biological Products(2.2)	Import Drug Application	2020-12-10	AbbVie Inc.	Abbvie Inc	In Review	2020-12-09	view